WHITE PAPER
Unlock expert insights into analytical method development, validation, and its role across the clinical development phase of drug development and pharmaceutical drug production. Britt Dam Raaby, Vice President, guides you through the critical steps to ensure your test methods are accurate, compliant, and ready for regulatory approval.
In today’s fast-paced industries, analytical development testing is key to ensuring product quality, safety, and regulatory compliance throughout the drug development lifecycle. From early process development in pharmaceutical environments to late-stage clinical development, it supports reliable method development and robust product validation.
Behind every breakthrough pharmaceutical or cutting-edge medical device lies a method built through critical steps to achieve accuracy, precision, and reliability. These analytical test methods are essential for detecting impurities, determining potency, and ensuring that a product meets regulatory standards. In this white paper, you’ll get tangible insights into every step in the development of test methods from idea to validation.
Analytical testing plays a vital role at every stage of the product lifecycle. It starts with route design, process analytical technology integration, and process development in pharmaceutical manufacturing. It continues through clinical trials and supports final product release.
Testing ensures that pharmaceutical and medical device materials are both effective and safe. It confirms safety by consistently assessing key attributes such as impurities, potency, and stability.
These evaluations form the foundation for product integrity and long-term reliability. They help protect patients and uphold product quality in the market.
To meet today’s complex regulatory demands, companies must take a proactive, structured approach to pharmaceutical analytical development. By combining advanced technologies with proven best practices, organizations ensure their test methods are both effective and fully regulation-compliant.
Strong pharmaceutical quality testing supports success from early research through to market approval. Aligning method development with frameworks like ICH Q2(R1) and FDA expectations improves consistency and speeds up review timelines.
Ensure your test methods are built for accuracy and compliance from day one. Avoid common pitfalls and accelerate your path to regulatory approval. Get expert insights from Britt Dam Raaby, Vice President, as she guides you through the critical steps to successful test development.
Developing and validating analytical methods often presents challenges. Navigating evolving regulations, especially with microbiological testing methods in pharmaceutical industry, is one of them. Requirements shift as products progress from development to commercialization.
Managing variability in test results (especially during the drug development pipeline) requires clear criteria and structured method development practices. Many pharmaceutical drug companies also face challenges related to evolving microbiological requirements and process analytical technologies.
Whether you’re building analytical test methods from scratch or refining existing ones, our Research & Development team offers deep expertise to ensure alignment with compliance needs and regulatory expectations. We help you select the right approach, implement variation control, and guide the development of evidence-based acceptance criteria to support full method validation.
No two analytical challenges are alike. That’s why our consulting solutions are tailored to your product, validation goals, and industry context. Whether addressing pharmaceutical testing methods or medical device protocols, we ensure your strategy is scientifically sound, compliant, and built to accelerate progress.
CASE SPOTLIGHT
A leading Nordic pharmaceutical company partnered with Emendo R&D to implement a new analytical test method for a novel drug substance in human clinical trials. The challenge? Transitioning the method from a non-GMP development unit to a GMP-regulated department with limited experience in the new method.
Emendo led the method development, validation, and implementation—aligning all activities with ICH Q2 guidelines and internal quality systems. Over 20 actions across 5 departments were coordinated, including SOP development, technician training, and analytical strategy design.
TAKE THE LEAD
From early drug dev stages to final method validation, every step matters. Whether you’re refining existing methods or building a new drug guide framework, our experts support your success through data-driven decisions and a regulatory-aligned approach.
Reach out to Britt Dam Raaby,Vice President at Emendo R&D, to learn how to navigate the critical steps with confidence.
TAKE THE LEAD
Method development is the systematic process of designing analytical procedures to accurately and consistently measure specific substances in regulated products.
It involves defining the test objective, choosing appropriate techniques, and setting parameters to ensure precision, accuracy, and reliability.
In the pharmaceutical industry, method development helps assess identity, purity, potency, and stability of drug substances to meet strict quality standards.
In the medical device sector, it ensures that materials and components comply with required safety and performance standards.
Method Development focuses on creating the test procedure—deciding what to measure, how to measure it, and which technology to use.
It involves selecting suitable analytical techniques and optimizing conditions to ensure consistent and reliable results.
Method Validation, by contrast, confirms that the developed method meets predefined performance criteria and is fit for its intended use.
It includes evaluating accuracy, precision, specificity, linearity, and robustness, following guidelines like ICH Q2(R1) and FDA standards.
Validation ensures the method produces reliable results under varied conditions. This is essential for regulatory submissions and quality assurance.
Analytical testing ensures pharmaceutical products meet quality standards required by regulatory bodies. By detecting impurities, confirming potency, and validating stability, testing helps maintain product safety and efficacy. It’s an essential part of both Good Manufacturing Practice (GMP) and clinical trial processes.
Common challenges include managing evolving regulatory requirements, variability in test results, aligning new methods with GMP environments, and developing microbiological test protocols. Structured development processes and expert consulting help mitigate these risks and streamline validation.
